House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008

Testimony of Dr. Andrew Maynard

Dr. Andrew Maynard

View

Today at the House Science and Technology Committee’s hearing on the National Nanotechnology Initiative Amendments Act of 2008, testimony highlighted shortfalls in the current U.S. Government Strategy. According to Dr. Andrew Maynard, without clear leadership and more transparency in federal risk research investment, the emergence of safe nanotechnologies will be a happy accident, rather than a foregone conclusion.